{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T12:46:22Z","timestamp":1785415582914,"version":"3.56.0"},"reference-count":46,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Charit\u00e9\u2014Universitaetsmedizin Berlin"},{"id":[{"id":"https:\/\/ror.org\/001w7jn25","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCDD"],"abstract":"<jats:p>Background: Cancer cachexia is a serious condition during the last stages of the disease, which is characterized by the loss of muscle and fat mass in patients with cancer. There are no effective treatments for cancer cachexia, and new treatment interventions are urgently needed. We have previously demonstrated that 5 mg\/kg\/day bisoprolol and 1.7 \u00b5g\/kg\/day ARA 284, a small non-erythropoietic tissue protective peptide, separately have positive effects in a rat model of cancer cachexia. Methods: We investigated the compound effects of both bisoprolol and ARA 284 by targeting multiple pathways in the Yoshida hepatoma rat model of cancer cachexia. Rats were randomly allocated to one of the following treatment groups: bisoprolol (5 mg\/kg\/day), ARA 284 (1.7 \u00b5g\/kg\/day), a 25% combination (1.25 mg\/kg\/day bisoprolol + 0.425 \u00b5g\/kg\/day ARA 284), a 75% combination (3.75 mg\/kg\/day bisoprolol + 1.275 \u00b5g\/kg\/day ARA 284), or placebo. Results: The combination of 3.75 mg\/kg\/day bisoprolol and 1.275 \u00b5g\/kg\/day ARA 284 showed the strongest overall effects compared with the respective effective monotherapies, respectively, or placebo across multiple endpoints, including body weight, lean mass, food intake, spontaneous activity, and cardiac function in a rat model of cancer cachexia (p &lt; 0.01, respectively). Furthermore, this combination therapy had the strongest effects on survival against the placebo (hazard ratio 0.08, 95% confidence interval 0.04 to 0.17, p &lt; 0.001). Conclusions: Our findings show that the combination of bisoprolol and ARA 284 is beneficial in a hepatoma cachexia model and may provide greater overall effects than either monotherapy alone.<\/jats:p>","DOI":"10.3390\/jcdd13060241","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T15:07:52Z","timestamp":1780326472000},"page":"241","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Combination Therapy with Bisoprolol and Tissue Protective Molecule ARA 284 Is Cardio-Protective and Improves Survival in Experimental Cancer Cachexia"],"prefix":"10.3390","volume":"13","author":[{"given":"Masatsugu","family":"Okamura","sequence":"first","affiliation":[{"name":"Berlin Institute of Health Center for Regenerative Therapies (BCRT), Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, 13353 Berlin, Germany"},{"name":"Department of Rehabilitation Medicine, School of Medicine, Yokohama City University, Yokohama 236-0004, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Palus","sequence":"additional","affiliation":[{"name":"Berlin Institute of Health Center for Regenerative Therapies (BCRT), Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, 13353 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfram","family":"D\u00f6ehner","sequence":"additional","affiliation":[{"name":"Berlin Institute of Health Center for Regenerative Therapies (BCRT), Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, 13353 Berlin, Germany"},{"name":"Deutsches Herzzentrum der Charit\u00e9, Department of Cardiology, Angiology and Intensive Care Medicine, Augustenburger Platz 1, 13353 Berlin, Germany"},{"name":"Center for Stroke Research Berlin, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, 13353 Berlin, Germany"},{"name":"German Centre for Cardiovascular Research (DZHK) Partner Site Berlin, 13092 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"von Haehling","sequence":"additional","affiliation":[{"name":"Department of Cardiology (CVK), Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, 13353 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan D.","family":"Anker","sequence":"additional","affiliation":[{"name":"German Centre for Cardiovascular Research (DZHK) Partner Site Berlin, 13092 Berlin, Germany"},{"name":"Department of Cardiology (CVK), Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, 13353 Berlin, Germany"},{"name":"Department of Cardiology and Pneumology, University of G\u00f6ttingen Medical Center (UMG), 37075 Goettingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Brines","sequence":"additional","affiliation":[{"name":"Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY 11030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Springer","sequence":"additional","affiliation":[{"name":"Berlin Institute of Health Center for Regenerative Therapies (BCRT), Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, 13353 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.critrevonc.2018.05.006","article-title":"Cancer cachexia: Diagnosis, assessment, and treatment","volume":"127","author":"Sadeghi","year":"2018","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.trecan.2018.10.001","article-title":"Cancer Cachexia: More Than Skeletal Muscle Wasting","volume":"4","author":"Schmidt","year":"2018","journal-title":"Trends Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","article-title":"Cachexia: A new definition","volume":"27","author":"Evans","year":"2008","journal-title":"Clin. Nutr."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s13539-013-0105-y","article-title":"Cachexia as a major public health problem: Frequent, costly, and deadly","volume":"4","author":"Farkas","year":"2013","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1200\/JCO.20.00611","article-title":"Management of Cancer Cachexia: ASCO Guideline","volume":"38","author":"Roeland","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Nishikawa, H., Goto, M., Fukunishi, S., Asai, A., Nishiguchi, S., and Higuchi, K. (2021). Cancer Cachexia: Its Mechanism and Clinical Significance. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22168491"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/j.jacc.2023.02.039","article-title":"Clinical and Prognostic Relevance of Cardiac Wasting in Patients with Advanced Cancer","volume":"81","author":"Lena","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1200\/JCO.23.01280","article-title":"Cancer Cachexia Expert Panel. Cancer Cachexia: ASCO Guideline Rapid Recommendation Update","volume":"41","author":"Roeland","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1007\/s12094-024-03502-8","article-title":"SEOM clinical guidelines for cancer anorexia-cachexia syndrome","volume":"26","year":"2024","journal-title":"Clin. Transl. Oncol."},{"key":"ref_10","first-page":"16135","article-title":"Sarcopenia and cachexia in chronic diseases: From mechanisms to treatment","volume":"131","author":"Lena","year":"2021","journal-title":"Pol. Arch. Intern. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1093\/eurheartj\/eht302","article-title":"Prevention of liver cancer cachexia-induced cardiac wasting and heart failure","volume":"35","author":"Springer","year":"2014","journal-title":"Eur. Heart J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/jcsm.12191","article-title":"Effect of beta-adrenergic blockade with carvedilol on cachexia in severe chronic heart failure: Results from the COPERNICUS trial","volume":"8","author":"Clark","year":"2017","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/ki.1997.52","article-title":"Sites of erythropoietin production","volume":"51","author":"Maxwell","year":"1997","journal-title":"Kidney Int."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ijcard.2016.05.008","article-title":"Erythropoietin improves cardiac wasting and outcomes in a rat model of liver cancer cachexia","volume":"218","author":"Saitoh","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1002\/jcsm.13009","article-title":"The erythropoietin-derived peptide ARA 284 reduces tissue wasting and improves survival in a rat model of cancer cachexia","volume":"13","author":"Palus","year":"2022","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s13539-011-0029-3","article-title":"IGF-1 treatment reduces weight loss and improves outcome in a rat model of cancer cachexia","volume":"2","author":"Schmidt","year":"2011","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s13539-011-0044-4","article-title":"Ursodeoxycholic acid treatment in a rat model of cancer cachexia","volume":"3","author":"Tschirner","year":"2012","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ijcard.2008.06.094","article-title":"No effects of human ghrelin on cardiac function despite profound effects on body composition in a rat model of heart failure","volume":"137","author":"Akashi","year":"2009","journal-title":"Int. J. Cardiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1042\/bj3440427","article-title":"Mammalian target of rapamycin is a direct target for protein kinase B- identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation","volume":"344","author":"Ouwens","year":"1999","journal-title":"Biochem. J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.devcel.2006.10.007","article-title":"Ablation in Mice of the mTORC Components raptor, rictor, or mLST8 Reveals that mTORC2 Is Required for Signaling to Akt-FOXO and PKC\u03b1, but Not S6K1","volume":"11","author":"Guertin","year":"2006","journal-title":"Dev. Cell"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Olson, B., Diba, P., Korzun, T., and Marks, D.L. (2021). Neural Mechanisms of Cancer Cachexia. Cancers, 13.","DOI":"10.3390\/cancers13163990"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"257","DOI":"10.4103\/0973-029X.86670","article-title":"Cancer cachexia","volume":"15","author":"Dhanapal","year":"2011","journal-title":"J. Oral Maxillofac. Pathol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1056\/NEJMoa010342","article-title":"Reversal of Catabolism by Beta-Blockade after Severe Burns","volume":"345","author":"Herndon","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"860","DOI":"10.7326\/0003-4819-121-11-199412010-00006","article-title":"Increased resting metabolic rate in patients with congestive heart failure","volume":"121","author":"Poehlman","year":"1994","journal-title":"Ann. Intern. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1152\/japplphysiol.00139.2002","article-title":"Myotoxic effects of clenbuterol in the rat heart and soleus muscle","volume":"93","author":"Burniston","year":"2002","journal-title":"J. Appl. Physiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/00005344-200304000-00003","article-title":"Characterization of adrenoceptor involvement in skeletal and cardiac myotoxicity Induced by sympathomimetic agent: Toward a new bioassay for beta-blockers","volume":"41","author":"Tan","year":"2003","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1054\/jcaf.2002.130238","article-title":"Effect of selective and nonselective beta-blockers on resting energy production rate and total body substrate utilization in chronic heart failure","volume":"8","author":"Podbregar","year":"2002","journal-title":"J. Card. Fail."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1172\/JCI109718","article-title":"Epinephrine-induced Insulin Resistance in Man","volume":"65","author":"Deibert","year":"1980","journal-title":"J. Clin. Investig."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/jcsm.12126","article-title":"Espindolol for the treatment and prevention of cachexia in patients with stage III\/IV non-small cell lung cancer or colorectal cancer: A randomized, double-blind, placebo-controlled, international multicentre phase II study (the ACT-ONE trial)","volume":"7","author":"Ho","year":"2016","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/jcsm.13116","article-title":"The atypical \u03b2-blocker S-oxprenolol reduces cachexia and improves survival in a rat cancer cachexia model","volume":"14","author":"Yuan","year":"2023","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/ejhf.2840","article-title":"Small molecule ACM-001 improves cardiac function in a rat model of cancer cachexia-induced cardiomyopathy","volume":"25","author":"Poetsch","year":"2023","journal-title":"Eur. J. Heart Fail."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"6541","DOI":"10.1002\/j.1460-2075.1996.tb01045.x","article-title":"Mechanism of activation of protein kinase B by insulin and IGF-1","volume":"15","author":"Alessi","year":"1996","journal-title":"EMBO J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"5960","DOI":"10.1200\/JCO.2005.06.150","article-title":"Maintaining Normal Hemoglobin Levels with Epoetin Alfa in Mainly Nonanemic Patients with Metastatic Breast Cancer Receiving First-Line Chemotherapy: A Survival Study","volume":"23","author":"Semiglazov","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"C391","DOI":"10.1152\/ajpcell.00478.2002","article-title":"Temporal alterations in protein signaling cascades during recovery from muscle atrophy","volume":"285","author":"Childs","year":"2003","journal-title":"Cell Physiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1113\/jphysiol.2002.036673","article-title":"Mitogen-activated protein kinase (MAPK) pathway activation: Effects of age and acute exercise on human skeletal muscle","volume":"547","author":"Williamson","year":"2003","journal-title":"J. Physiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/387083a0","article-title":"Regulation of skeletal muscle mass in mice by a new TGF-\u03b2 superfamily member","volume":"387","author":"McPherron","year":"1997","journal-title":"Nature"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s13539-011-0035-5","article-title":"The role of myostatin in muscle wasting: An overview","volume":"2","author":"Elkina","year":"2011","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/jcsm.12528","article-title":"Cancer cachexia and its pathophysiology: Links with sarcopenia, anorexia and asthenia","volume":"11","author":"Santos","year":"2020","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jcsm.12673","article-title":"Nutrition in the spotlight in cachexia, sarcopenia and muscle: Avoiding the wildfire","volume":"12","author":"Prado","year":"2020","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1200\/JCO.2012.45.2722","article-title":"Cancer Cachexia in the Age of Obesity: Skeletal Muscle Depletion Is a Powerful Prognostic Factor, Independent of Body Mass Index","volume":"31","author":"Martin","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/jcsm.12698","article-title":"The prognostic value of weight and body composition changes in patients with non-small-cell lung cancer treated with nivolumab","volume":"12","author":"Degens","year":"2021","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1002\/jcsm.13095","article-title":"Associations between body mass index, weight loss and overall survival in patients with advanced lung cancer","volume":"13","author":"Oswalt","year":"2022","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Finke, D., Heckmann, M.B., Frey, N., and Lehmann, L.H. (2021). Cancer-A Major Cardiac Comorbidity with Implications on Cardiovascular Metabolism. Front. Physiol., 12.","DOI":"10.3389\/fphys.2021.729713"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Wiggs, M.P., Beaudry, A.G., and Law, M.L. (2022). Cardiac Remodeling in Cancer-Induced Cachexia: Functional, Structural, and Metabolic Contributors. Cells, 11.","DOI":"10.3390\/cells11121931"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/jcsm.12694","article-title":"Advanced cancer is also a heart failure syndrome: A hypothesis","volume":"12","author":"Anker","year":"2021","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00395-024-01079-5","article-title":"Cardiac wasting in patients with cancer","volume":"120","author":"Anker","year":"2025","journal-title":"Basic Res. Cardiol."}],"container-title":["Journal of Cardiovascular Development and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2308-3425\/13\/6\/241\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T15:38:22Z","timestamp":1780328302000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2308-3425\/13\/6\/241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":46,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["jcdd13060241"],"URL":"https:\/\/doi.org\/10.3390\/jcdd13060241","relation":{},"ISSN":["2308-3425"],"issn-type":[{"value":"2308-3425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]}}}